Assistant Investigator, The Feinstein Institute for Medical Research
Assistant Professor of Psychiatry, Hofstra North Shore LIJ School of Medicine
Phone: (718) 470-8177
Dr. Gallego is currently an Assistant Professor at Hofstra North-Shore LIJ School of Medicine and an Assistant Investigator at the Feinstein Institute for Medical Research. Dr. Gallego completed his residency training in psychiatry at SUNY Downstate Medical Center in Brooklyn and a research fellowship at The Zucker Hillside Hospital, the psychiatric hospital for the North Shore LIJ Health System.
Dr. Gallego has a strong background in clinical research. He obtained a master’s degree in clinical research methods at Albert Einstein College of Medicine and has participated as a study physician and co-investigator in various randomized controlled trials with first episode schizophrenia patients, such as the Prevent First Episode Relapse PREFER study (ClinicalTrials.gov ID: NCT00220714) and the Comparison of aripiprazole and risperidone for the treatment of people with First-Episode Psychosis study (ClinicalTrials.gov ID: NCT00320671). In addition, Dr. Gallego has coauthored several papers in the topic of schizophrenia (Gallego et al, 2011; Gallego et al, 2012a; Gallego et al, 2012b; Peters et al, 2012; Ikuta et al, 2012; Zhang et al, 2012; Toteja et al, 2013).
For the past few years, Dr. Gallego adopted a translational approach to his work. His current research focus is on the role of microRNAs in cerebrospinal fluid and peripheral blood in patients with schizophrenia (Gallego et al., 2012c). Pilot data suggests that a number of microRNAs are differentially expressed in patients with schizophrenia compared to healthy volunteers (Gallego et al, 2013 – in preparation). Notably, Dr, Gallego just received an NIMH K23 Career Development Award that will support this project.
In collaboration with other investigators at the Feinstein Institute and the Hofstra North Shore LIJ School of Medicine, Dr. Gallego will expand his research operations by investigating the relationship between microRNAs and clinical symptoms (PI: Delbert G. Robinson, MD), genetic variations (PIs: Anil K. Malhotra, MD; Todd Lencz, PhD) and neuroimaging measures (PI: Phillip Szeszko, PhD).